Tenet Healthcare Corporation (THC) Q2 FY26 Earnings Call

Strong operations and cost control drove a sizable guidance increase despite persistent exchange-related revenue pressure.

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Length56 minutes
EPS$6.12
EPS consensus$4.08

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q1 FY26 · Q4 FY25 · Q2 FY25

All THC earnings · Back to THC overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.